Business OpportunitiesSun Pharma up on new support in Taro war
Sun Pharma ended at its intra-day high of Rs 1542, stronger by Rs 38 or 2.5% on the BSE.
- Sun TV up on restructuring plans - Nalco up on hike in prices - Sun pharma gets fresh support in Taro battle - Nava Bharat soars on acquiring 65% Zambian coal mine - M&M erases gains, ends down 1% - More support for Sun Pharma in Taro takeover battle
The stock had opened at Rs 1513 and touched a high of Rs 1505 during the day.
____________________________________________________________________________________
(Updated at 1150am)
Sun Pharmaceutical Industries is up on getting more support from independent advisory firms in its battle to acquire Israeli drug major Taro Pharmaceutical Industries.
The stock opened at Rs 1,513 and soared to a high of Rs 1,524. The scrip is now trading at Rs 1,523, up 1% from its previous close. The counter clocked volumes of 5,373 shares as compared to the two-week dailya verage traded volumes of 20,294 shares on the BSE.